Compagnie Lombard Odier S Cm A Exact Sciences Corp Transaction History

Compagnie Lombard Odier S Cm A

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 27, 2022	SELL	$57.56 - $82.54 $28,780 - $41,270	-500 Reduced 50.0%	500 $35,000
Q3 2021 Oct 28, 2021	SELL	$90.24 - $124.05 $221,088 - $303,922	-2,450 Reduced 71.01%	1,000 $95,000
Q2 2021 Jul 15, 2021	SELL	$93.66 - $139.27 $13.5 Million - $20 Million	-143,610 Reduced 97.65%	3,450 $429,000
Q1 2021 Apr 23, 2021	BUY	$116.57 - $155.01 $16.8 Million - $22.4 Million	144,310 Added 5247.64%	147,060 $19.4 Million
Q4 2020 Feb 09, 2021	BUY	$99.61 - $142.12 $29,883 - $42,636	300 Added 12.24%	2,750 $365,000
Q4 2019 Feb 13, 2020	BUY	$77.66 - $99.74 $190,267 - $244,363	2,450 New	2,450 $227,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.